Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Solute carrier family 2 member 4 (SLC2A4) is a multi-pass integral membrane facilitated glucose transporter belonging to the SLC2 solute-carrier family, encoded by the SLC2A4 gene, predominantly expressed within muscle and adipose-derived tissue populations. Distinct from soluble cytosolic metabolic mediators, SLC2A4 contains repeated conserved transmembrane helical segments forming substrate-permeating structural folds, lacks independent intracellular catalytic effector domains. It appears to operate as a signal-responsive metabolic modulator that mediates facilitated hexose substrate translocation across plasma-membrane compartments under basal physiological conditions. Disordered cellular glucose acquisition and unbalanced systemic carbohydrate homeostasis readily emerge without sufficient membrane-resident transporter factors, and SLC2A4 tends to deliver moderate metabolic buffering to sustain balanced glucose uptake across insulin-sensitive tissue niches. Different tissue compartments generate distinct sugar-substrate molecular mixes, requiring diversified solute-carrier pools to maintain overall cellular-metabolism equilibrium within multicellular tissue systems. Membrane-embedded SLC2A4 might continuously engage hexose-containing substrate assemblies to restrain aberrant glucose-metabolic-profile shifts and preserve steady local tissue functional balance.
Variants of the SLC2A4 gene might alter substrate-transport affinity and correlate with rearranged carbohydrate-metabolic profiles, and no other SLC2 family member fully reproduces the dual capacity of SLC2A4 for glucose-substrate translocation and regulated plasma-membrane deployment. Shifts in SLC2A4 expression levels likely align with systemic insulin-signaling status, rendering it a suitable research subject for multi-pass solute-carrier and glucose-homeostasis-regulation analysis. SLC2A4 can be stored within intracellular vesicle compartments and trafficked toward surface lipid bilayers upon upstream signal input, mediating substrate translocation without constitutive persistent intracellular signal-cascade activation; its condition-dependent cell-surface localization separates it from constitutively-localized solute carriers, carrying dual potential to support stimulus-coupled hexose import and mediate selective sugar-substrate molecular recognition. Diminished functional SLC2A4 could perturb insulin-responsive glucose acquisition and weaken local carbohydrate-metabolism buffering capacity, further validating research value for fundamental facilitated-transporter family protein studies.
Fig. 1 Compartment‑cycling model for SLC2A4(GLUT4). SLC2A4 may shuttle among plasma‑membrane, GSV storage‑vesicle pool and endosomal recycling compartments.1
The biological functions of transmembrane SLC2A4 glucose-transporter protein are focused on sustained sugar-substrate engagement and insulin-sensitive metabolic coordination:
Creative Biolabs offers purified SLC2A4 membrane samples produced under unified preparation workflows, including full-length SLC2A4 constructs and isolated transmembrane-domain variants. Truncated domain fragments cannot support complete hexose-substrate-translocation behaviours, while full-length constructs suit research focused on solute-carrier-substrate interaction and regulated membrane-deployment functional observation. All batches receive uniform quality screening. Functional relevant observation may only be carried out with full-length samples under simulated plasma-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length SLC2A4 samples retain intact sugar-permeation structural-fold conformation after standardized purification, which supports reliable detection of weak and transient carrier-substrate contacts for comparative functional analysis.
Not finding the Membrane potein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable SLC2A4 expression cell research models with varied expression levels, applicable to structural observation of multi-pass facilitated-transporter proteins and research into hexose-substrate molecular interaction. Sample evaluation includes sustained target expression detection and preliminary substrate-interaction observation, enabling side-by-side comparison of carrier-transport behaviours under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in substrate-translocation efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-SLC2A4 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma-membrane and intracellular-vesicle localization mapping and identification of solute-carrier associated molecular complexes. The antibody series can work alongside common laboratory detection reagents to realize multi-dimensional observation of target distribution within insulin-sensitive tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for SLC2A4 research:
SLC2A4 might act as a multi-pass insulin-responsive facilitated glucose transporter and participate in hexose-substrate translocation to modulate cellular glucose acquisition and metabolic homeostasis.
SLC2A4 expression status could alter glucose-substrate translocation efficiency and local carbohydrate metabolic balance, serving as a major regulatory mediator of insulin-sensitive tissue biological processes.
No, SLC2A4-associated research reagents from Creative Biolabs are specially developed for exploring insulin-linked glucose-transport mechanisms, and should never be utilized for any clinical application scenarios. These preparations are optimized for basic metabolic research and do not meet rigorous performance criteria required for clinical deployment.
Offerings include full-length SLC2A4 membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on insulin-sensitive tissue homeostasis and solute-carrier-mediated hexose substrate translocation.
Laboratory observation schemes may include carrier-substrate interaction related tests to analyse molecular-binding associated behaviors under simulated cell-membrane environments.
